Innoviva (INVA) Change in Taxes (2022 - 2026)
Innoviva posted quarterly Change in Taxes of $1.1 million for Q1 2026, down 55.47% year-on-year from $2.4 million in Q1 2025, and down 60.06% on a QoQ basis from $2.6 million in Q3 2025.
Innoviva (INVA) has 5 years of Change in Taxes data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Taxes fell 55.47% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (down 1.09% YoY), and the FY2025 full-year result was $4.1 million, down 90.21% from the prior year.
- Change in Taxes for Q1 2026 stood at $1.1 million, down from $2.6 million in the prior quarter.
- Across five years, Change in Taxes topped out at $33.8 million in Q3 2022 and bottomed at -$455000.0 in Q2 2025.
- The 5-year median for Change in Taxes is $494000.0 (2024), against an average of $3.9 million.
- Peak annual rise in Change in Taxes reached 4748.98% in 2025, while the deepest fall reached 192.11% in 2025.
- A 5-year view of Change in Taxes shows it stood at $33.8 million in 2022, then slumped by 99.56% to $148000.0 in 2023, then soared by 1772.3% to $2.8 million in 2024, then retreated by 4.4% to $2.6 million in 2025, then slumped by 60.06% to $1.1 million in 2026.
- The last three Change in Taxes figures came in at $1.1 million (Q1 2026), $2.6 million (Q3 2025), and -$455000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | -455,000.00 |
| Jun 30, 2025 | -455,000.00 |
| Mar 31, 2025 | 2.38 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 494,000.00 |
| Jun 30, 2024 | 494,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Sep 30, 2022 | 33.80 Mn |
| Sep 30, 2022 | 33.80 Mn |